XML 49 R35.htm IDEA: XBRL DOCUMENT v3.24.0.1
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2023
Income Tax Disclosure [Abstract]  
Schedule of Income before Income Tax, Domestic and Foreign
For financial reporting purposes, income before taxes includes the following components (in thousands):
Years ended December 31,
202320222021
Domestic$(4,111)$(4,979)$(5,956)
Foreign42,547 50,067 31,868 
$38,436 $45,088 $25,912 
Schedule of Components of Income Tax Expense (Benefit)
The expense (benefit) for income taxes is comprised of (in thousands):
Years ended December 31,
202320222021
Current:
Federal$517 $21 $245 
State and local162 97 38 
Foreign11,903 10,457 8,442 
12,582 10,575 8,725 
Deferred:
Federal154 (2,808)(2,992)
State and local(628)109 (588)
Foreign318 659 324 
(156)(2,040)(3,256)
Total income tax expense $12,426 $8,535 $5,469 
Schedule of Effective Income Tax Rate Reconciliation
A reconciliation of income tax expense (benefit) at the U.S. federal statutory income tax rate to the actual income tax provision is as follows (in thousands):
Years ended December 31,
202320222021
Tax at statutory rate$8,072 $9,468 $5,441 
State income taxes, net of U.S. federal tax benefit(368)164 (391)
U.S. GILTI tax, net of foreign tax credits72 8 77 
Effect of foreign operations2,378 1,246 2,096 
Residual U.S. tax on foreign earnings899 291 (258)
Change in valuation allowance1,270 (1,629)(1,204)
Change in unrecognized tax benefits, net476 (1,000)107 
Impairment of goodwill — 237 
Specialty tax credits(520)(639)(333)
Statutory rate changes56 (282)
Effect of foreign exchange128 667 (35)
Other(37)(44)14 
Total income tax expense $12,426 $8,535 $5,469 
Schedule of Deferred Tax Assets and Liabilities
Significant components of the Company’s deferred tax assets and liabilities are as follows (in thousands):
December 31,
20232022
Deferred tax assets:
Pension and other postretirement costs$1,082 $1,775 
Inventories4,102 4,057 
Net operating/capital loss and interest carryforwards10,800 9,060 
Tax credit carryforwards1,390 2,372 
Deferred compensation2,845 2,921 
Research and development costs4,707 2,940 
Other accruals and reserves3,709 2,228 
Total gross deferred tax assets28,635 25,353 
Less: valuation allowance(13,136)(10,726)
15,499 14,627 
Deferred tax liabilities:
Tax over book depreciation(2,151)(1,453)
Investment in subsidiary(2,121)(2,137)
Intangible assets, including tax deductible goodwill(10,843)(10,675)
Total gross deferred tax liabilities(15,115)(14,265)
Net deferred tax assets$384 $362 
Summary of Valuation Allowance
Significant valuation allowances are as follows (in thousands):
December 31,
Jurisdiction20232022
U.S. federal$4,402 $2,647 
U.S. state (net of U.S. federal tax benefit)6,545 6,026 
Israel - capital losses1,369 1,287 
Summary of Operating Loss Carryforwards
The following table summarizes significant net operating losses, capital losses and credit carryforwards as of December 31, 2023 (in thousands):
December 31,
Jurisdiction2023Expiring
U.S. federal net operating losses$3,566 No expiration
U.S. federal interest expense carryover12,209 No expiration
U.S. foreign tax credit577 2028-2032
U.S. state net operating losses120,710 2023-2042
Israel capital losses5,928 No expiration
Summary of Income Tax Contingencies
The following table summarizes changes in the Company's gross liabilities, excluding interest and penalties, associated with unrecognized tax benefits (in thousands):
December 31,
202320222021
Balance at beginning of year$439 $1,282 $1,244 
Addition based on tax positions related to current year589 176 52 
Addition based on tax positions related to prior years 216 — 
Reduction based on tax positions related to prior years(128)— — 
Currency translation adjustments(8)(6)41 
Reduction for settled tax examinations (1,229)— 
Reduction for payments made(94)— — 
Reduction for lapses of statute of limitations— — (55)
Balance at end of year$798 $439 $1,282